Abstract

The Glial cell line-derived neurotrophic Family Ligands (GFL) are soluble neurotrophic factors that are required for development of multiple human tissues, but which are also important contributors to human cancers. GFL signaling occurs through the transmembrane RET receptor tyrosine kinase, a well-characterized oncogene. GFL-independent RET activation, through rearrangement or point mutations occurs in thyroid and lung cancers. However, GFL-mediated activation of wildtype RET is an increasingly recognized mechanism promoting tumor growth and dissemination of a much broader group of cancers. RET and GFL expression have been implicated in metastasis or invasion in diverse human cancers including breast, pancreatic, and prostate tumors, where they are linked to poorer patient prognosis. In addition to directly inducing tumor growth in these diseases, GFL-RET signaling promotes changes in the tumor microenvironment that alter the surrounding stroma and cellular composition to enhance tumor invasion and metastasis. As such, GFL RET signaling is an important target for novel therapeutic approaches to limit tumor growth and spread and improve disease outcomes.

Highlights

  • The neurotrophins are a family of soluble neurotrophic factors, originally recognized for their abilities to regulate growth, survival and differentiation of neural-derived cell types

  • There are four structurally similar family members: Glial Cell-line Derived Neurotrophic Factors (GDNF), neurturin (NRTN), artemin (ARTN), and persephin (PSPN) that are recruited to corresponding non-signaling co-receptors of the GDNF Family Receptors α (GFRα1-4), which are tethered to the plasma membrane through glycosylphosphatidylinositol-anchors (Airaksinen and Saarma, 2002; Figure 1)

  • GDNF Family Ligands (GFL) and GFRα family members have distinct but overlapping tissue-specific expression patterns that determine their biological roles, all GFL-GFRα complexes signal through a single transmembrane receptor, the RET (REarranged during Transfection) tyrosine kinase (Mulligan, 2014)

Read more

Summary

INTRODUCTION

The neurotrophins are a family of soluble neurotrophic factors, originally recognized for their abilities to regulate growth, survival and differentiation of neural-derived cell types. Neurotrophins have well characterized roles as guidance, survival and differentiation factors in developing neurons in the central (CNS) and peripheral nervous systems (PNS) and may promote survival or regrowth of mature neurons, by binding their cell-surface receptors and stimulating downstream signals in their target cells. With the increasing availability of tissue and cell-specific transcriptome and proteome data, it is becoming clear that neurotrophic factors and their receptors are broadly expressed on other, non-neural cell types, where they can contribute to cell growth, differentiation and migration and tissue maturation. The aberrant expression or activation of these signaling complexes can allow these normal growth signals to contribute to the growth or spread of cancer cells, making expression and functions of neurotrophins and their receptors important contributors to human cancer, and potentially valuable therapeutic targets

THE GDNF FAMILY AND RET RECEPTOR
RET Gene Rearrangements
RET Point Mutations
Breast Cancer
Pancreatic Cancer
Prostate Cancer
Colorectal Cancer
Myeloid Malignancies
Findings
Other Cancers

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.